# Omission of ALND in Breast Cancer Patients With Axillary pCR

> **NCT05939830** · NA · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 92 (estimated)

## Conditions studied

- Axillary Lymph Node Dissection
- Pathological Complete Response
- Neoadjuvant Systemic Therapy
- Breast Cancer
- Axillary Lymph

## Interventions

- **PROCEDURE:** Stained region Lymph Node Biopsy (SrLNB)
- **RADIATION:** Regional lymph node radiotherapy (RNI) including the axilla

## Key facts

- **NCT ID:** NCT05939830
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-11
- **Primary completion:** 2025-07
- **Final completion:** 2026-07
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939830, "Omission of ALND in Breast Cancer Patients With Axillary pCR". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05939830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*